Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial

John Cronin, Una Kennedy, Siobhan McCoy, Sinéad Nic An Fhailí, Gloria Crispino-O'Connell, John Hayden, Abel Wakai, Sean Walsh, Ronan O'Sullivan, John Cronin, Una Kennedy, Siobhan McCoy, Sinéad Nic An Fhailí, Gloria Crispino-O'Connell, John Hayden, Abel Wakai, Sean Walsh, Ronan O'Sullivan

Abstract

Background: Asthma is a major cause of pediatric morbidity and mortality. In acute exacerbations of asthma, corticosteroids reduce relapses, subsequent hospital admission and the need for ß₂-agonist therapy. Prednisolone is relatively short-acting with a half-life of 12 to 36 hours, thereby requiring daily dosing. Prolonged treatment course, vomiting and a bitter taste may reduce patient compliance with prednisolone. Dexamethasone is a long-acting corticosteroid with a half-life of 36 to 72 hours. It is used frequently in children with croup and bacterial meningitis, and is well absorbed orally. The purpose of this trial is to examine whether a single dose of oral dexamethasone (0.3 mg/kg) is clinically non-inferior to prednisolone (1 mg/kg/day for three days) in the treatment of exacerbations of asthma in children who attend the Emergency Department.

Methods/design: This is a randomized, non-inferiority, open-label clinical trial. After informed consent with or without assent, patients will be randomized to either oral dexamethasone 0.3 mg/kg stat or prednisolone 1 mg/kg/day for three days. The primary outcome measure is the comparison between the Pediatric Respiratory Assessment Measure (PRAM) across both groups on Day 4. The PRAM score, a validated, responsive and reliable tool to determine asthma severity in children aged 2 to 16 years, will be performed by a clinician blinded to treatment allocation. Secondary outcomes include relapse, hospital admission and requirement for further steroid therapy. Data will be analyzed on an intention-to-treat and a per protocol basis. With a sample size of 232 subjects (105 in each group with an estimated 10% loss to follow-up), we will be able to reject the null hypothesis - that the population means of the experimental and control groups are equal with a probability (power) of 0.9. The Type I error probability associated with this test (of the null hypothesis) is 0.05.

Discussion: This clinical trial may provide evidence that a shorter steroid course using dexamethasone can be used in the treatment of acute pediatric asthma, thus eliminating the issue of compliance to treatment.

Registration: ISRCTN26944158 and EudraCT Number 2010-022001-18.

References

    1. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2007;18(3):CD000195. Review.
    1. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;1:CD002178. Review.
    1. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: A National Clinical Guideline. British Thoracic Society, London; 2008.
    1. Schimmer BP, Parker K. In: Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogues; inhibitors of the syntheses and actions of adrenocortical hormones. 11. Brunton L, Lazo J, Parker K, editor. The McGraw-Hill Companies, Inc, Columbus, Ohio; 2006. Goodman and Gilman’s The Pharmacological Basis of Therapeutics.
    1. Matsui D, Joubert GI, Dykxhoorn S, Rieder MJ. Compliance with prescription filling in the pediatric emergency department. Arch Pediatr Adolesc Med. 2000;154(2):195–198.
    1. Butler K, Cooper WO. Adherence of pediatric asthma patients with oral corticosteroid prescriptions following pediatric emergency department visit or hospitalization. Pediatr Emerg Care. 2004;20:730–735.
    1. Lucas-Bouwman ME, Roorda RJ, Jansman FG, Brand PL. Crushed prednisolone tablets or oral solution for acute asthma? Arch Dis Child. 2001;84(4):347–348. doi: 10.1136/adc.84.4.347.
    1. Russell K, Wiebe N, Saenz A, Ausejo SM, Johnson D, Hartling L, Klassen TP. Glucocorticoids for croup. Cochrane Database of Systematic Reviews. 2004. p. CD001955.
    1. Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003;361(9375):2139–2148. doi: 10.1016/S0140-6736(03)13693-8. Review.
    1. Ebrahimi S, Sarkari B. Comparative efficacy of dexamethasone versus hydrocortisone in severe acute pediatric asthma. Iran J Allergy Asthma Immunol. 2007;6:159–160.
    1. Hames H, Seabrook JA, Matsui D, Rieder MJ, Joubert GI. A palatability study of a flavored dexamethasone preparation versus prednisolone liquid in children. Can J Clin Pharmacol. 2008;15:e95–e98.
    1. Klig JE, Hodge D 3rd, Rutherford MW. Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. J Asthma. 1997;34:419–425. doi: 10.3109/02770909709055384.
    1. Gries DM, Moffitt DR, Pulos E, Carter ER. A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. J Pediatr. 2000;136:298–303. doi: 10.1067/mpd.2000.103353.
    1. Qureshi F, Zaritsky A, Poirier MP. Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr. 2001;139:20–26. doi: 10.1067/mpd.2001.115021.
    1. Altamimi S, Robertson G, Jastaniah W, Davy A, Dehghani N, Chen R, Leung K, Colbourne M. Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. Pediatr Emerg Care. 2006;22:786–793. doi: 10.1097/01.pec.0000248683.09895.08.
    1. Gordon S, Tompkins T, Dayan PS. Randomized trial of single-dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatr Emerg Care. 2007;23:521–527. doi: 10.1097/PEC.0b013e318128f821.
    1. Greenberg RA, Kerby G, Roosevelt GE. A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. Clin Pediatr (Phila) 2008;47:817–823. doi: 10.1177/0009922808316988.
    1. Scarfone RJ, Loiselle JM, Wiley JF 2nd, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med. 1995;26:480–486. doi: 10.1016/S0196-0644(95)70118-4.
    1. Babl FE, Sheriff N, Borland M, Acworth J, Neutze J, Krieser D, Ngo P, Schutz J, Thomson F, Cotterell E, Jamison S, Francis P. Paediatric acute asthma management in Australia and New Zealand: practice patterns in the context of clinical practice guidelines. Arch Dis Child. 2008;93:307–312.
    1. Chang AB, Clark R, Sloots TP, Stone DG, Petsky HL, Thearle D, Champion AA, Wheeler C, Acworth JP. A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Med J Aust. 2008;189:306–310.
    1. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, Meng L, McGillivray D. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr. 2008;152:476–480. doi: 10.1016/j.jpeds.2007.08.034.
    1. Birken CS, Parkin PC, Macarthur C. Asthma severity scores for preschoolers displayed weaknesses in reliability, validity, and responsiveness. J Clin Epidemiol. 2004;57:1177–1181. doi: 10.1016/j.jclinepi.2004.02.016.
    1. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, Grigg J. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med. 2009;360:329–338. doi: 10.1056/NEJMoa0804897.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다